Abstract

Dental implant surgery has developed into a widely used procedure for dental rehabilitation and is a secure and predictable procedure. Local and systemic factors can result in higher failure rates. Hypertension is a chronic disease that goes in with atherosclerosis, and coronary artery disease which causes multifarious side effects. Hypertension as a relative contraindication for implant surgery is controversially discussed. Because the number of patients suffering from hypertension increases, therefore more hypertensive patients demand implant procedures. We also conclude that patients with poorly controlled blood pressure suffer from impaired osseointegration, elevated risk of peri-implantitis, and a higher level of implant failure. The influence of the disease is not fully clear. The supportive administration of antibiotics and chlorohexidine seems to improve implant success. When hypertension is under well control, implant procedures are safe and predictable with a complication rate similar to that of healthy patients.

• 1.   Jemt T (1993) Implant treatment in resorbed edentulous upper jaws. Clin Oral Impl Res 4(4): 187-194.
• 2.   Coulthard P (2002) Should be checking blood pressure. Br Dent J 193 (5). 3. Greenwood M, Jowry RJ (2002) Blood pressure measuring equipment in the dental surgery: Use or ornament? Br Dent J 193 (5): 273-275.
• 3.   Greenwood M, Jowry RJ (2002) Blood pressure measuring equipment in the dental surgery: Use or ornament Br Dent J 193 (5): 273-275.
• 4.   Halberg E, Delmore P, Finch M, Cornelissen G, Halberg F. Chronobiologic assessment of
• 5.   Little JW, Halberg F. A new horizon in the prevention, diagnosis, and treatment of
• 6.   MacDonald MB, Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ 1999.
• 7.   TrucThi Hoang Nguyen*, Mi Young Eo*, Yun Ju Cho, HoonMyoung, Soung Min Kim.
• 8.   British Dental Journal Volume 189 no. 6 September 23 2000.
• 9.   C. Scully*, J. Hobkirk* & P. D DIOS†, Journal of Oral Rehabilitation 2007 34; 590–599.
• 10.   Schwartz AD, Bar TY, Ilana E (2007) Effect of on information processing in the dental implant surgery setting. Clin Oral Impl Res 18(1): 9-12.
• 11.   Brand HS, Gortzaak RA, Palmer BC, Abraham RE, Abraham IL (1995) Cardiovascular and
• 12.   Gortzak RA, Dosting J, Abraham IL (1992) Blood pressure response to routine restorative dental treatment without local anesthesia. Continuous non-invasive blood pressure registration with a finger manometer. Oral Surg Oral Med Oral Pathol 73(6): 677-681.
• 13.   Wu X, Abedalla K, Elmar H, Daniel NG, Nicolau B, et al. (2016) Antihypertensive medications and survival rate of osseointegrated dental implants: A cohort study. Clin Implant Dent Relat Res 18[6]: 1171-1182.
• 14.   Intro bad Wala. 7. Diego RG, Gomez-de Diego R, la Rosa MM, Romero-Perez MJ, Cutando-Soriano A, Lopez-Valverde-Centeno A. Indications and contraindications of dental implants in medically.
• 15.   Akay AS, Arısan V. Dental Implants in the Medically Compromised Patient Population
• 16.   Singh S, Shankar R, Singh GP. Prevalence and Associated Risk Factors of Hypertension: A CrossSectional Study in Urban Varanasi [Internet]. Vol. 2017, International Journal of Hypertension. 2017. p. 1–10
• 17.   Khadivi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with
• 18.   Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions [Internet]. Vol. 380, The Lancet. 2012. p. 601–10.
• 19.   Group H in DS, Hypertension in Diabetes Study Group. Hypertension in Diabetes Study III. Prospective Study of Therapy of Hypertension in Type 2 Diabetic Patients: Efficacy of ACE
• 20.   Stamler J, Vaccaro O, Neaton JD, Wentworth D, The Multiple Risk Factor Intervention Trial Research Group. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial [Internet]. Vol. 16, Diabetes Care. 1993. p. 434–44.
• 21.   Scheuber S, Hicklin S, Brägger U. Implants versus short-span fixed bridges: survival, complications, patients’ benefits. A systematic review of economic aspects. Clin Implants Res. 2012 Oct;23 Suppl 6:50– 62.
• 22.   Ramesh A, Ravi S, Karthikeyan G. Comprehensive rehabilitation using dental implants in generalized aggressive periodontitis. J Indian Soc Periodontal. 2017 Mar;21(2):160–3.
• 23.   Brägger U, Krenander P, Lang NP. Economic aspects of single-tooth replacement. Clin Oral Implants Res. 2005 Jun;16(3):335–41.
• 24.   Mulinari-Santos G, de Souza Batista FR, Kirchweger F, Tang S, Gruber R, Okamoto R.
• 25.   Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 [Internet]. Vol. 49, Hypertension. 2007. p. 69–75.
• 26.   Nikolopoulou, Anestis Chrysostomidis. Hypertension and Dental Implants: A Review.
• 27.   Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study [Internet]. Vol. 354, The Lancet. 1999. p. 971–5.
• 28.   Strazzullo P, Nunziata V, Cirillo M, Giannattasio R, Ferrara LA, Mattioli PL, et al. Abnormalities of Calcium Metabolism in Essential Hypertension [Internet]. Vol. 65, Clinical Science. 1983. p. 137–41.
• 29.   Puleo D. Understanding and controlling the boneimplant interface [Internet]. Vol. 20, Biomaterials. 1999. p. 2311–21.27. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, et al. Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension [Internet]. Vol. 24, Journal of Bone and Mineral
• 30.   Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, et al. Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension [Internet]. Vol. 24, Journal of Bone and Mineral Research.
• 31.   Abuohashish HM, Ahmed MM, Sabry D, Khattab MM, Al-Rejaie SS. The ACE-2/Ang1- 7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade [Internet]. Vol. 807, European Journal of Pharmacology. 2017. p. 44–55.
• 32.   Van Steenberg he D, Jacobs R, Desnyder M, et al. The relative impact of local and endogenous patient-related factors on implant failure up to the abutment stage. Clin Oral Implants Res. 2002;13: 617-622.
• 33.   Perez-Castrillon JL, Justo I, Sanz-Cantalapiedra A, Pueyo C, Hernandez G, Duenas A. Effect of the antihypertensive treatment on the bone mineral density and osteoporotic fracture. CurrHypertens Rev 2005; 1:61–66.
• 34.   Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of b-blockers and risk of fractures. JAMA 2004; 292: 1326–1332.
• 35.   Duarte JD, Cooper-De Hoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther 2010; 8:793–802.
• 36.   Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors,
• 37.   Pierroz DD, Bonnet N, Bianchi EN, et al. Deletion of adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res 2012; 27:1252–1262.
• 38.   Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005; 434:514–520.
• 39.   Albrektsson T, Bra˚nemark P-I, Hansson H-A, Lindstrom€ J. Osseointegrated titanium implants: requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. ActaOrthop 1981; 52:155–170.
• 40.   Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures
• 41.   Puleo D, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999; 20:2311–2321.
• 42.   Ghosh M, Majumdar SR. Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provide new insights into osteoporosis. Endocrine 2014; 46:397–405
• 43.   Walker RL, Chen G, Campbell NR, et al. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006. Can J Cardiol 2011; 27:461–467.
• 44.   Moore RE, Smith CK, II, Bailey CS, Voelkel EF, Tashjian AH, Jr. Characterization of betaadrenergic receptors on rat and human osteoblastlike cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 1993; 23:301–315.
• 45.   Bazzini C, Vezzoli V, Sironi C, et al. Thiazidesensitive NaCl-cotransporter in the intestine
• 46.   Aubin R, Menard P, Lajeunesse D. Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int 1996; 50:1476–1482.
• 47.   Nakagami H, Osako MK, Morishita R. Potential effect of angiotensin II receptor blockade in adipose tissue and bone. Curr Pharm Des 2013; 19:3049–3053.
• 48.   Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors,
• 49.   Scully C, Hobkirk J, Dios PD (2007) Dental endosseous implants in the medically
• 50.   Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High
• 51.   Alvarez Li FC, Espinosa Brito AD, Ordunez Garcia PO, Silva Aycaguer LC. Risk markers and high blood pressure. The Cienfuegos Global Project. Longitudinal study 1992-1994. Rev Invest Clin 1999.
• 52.   Beilin LJ, Puddey IB, Burke V. Lifestyle and hypertension. Am J Hypertens1999.
• 53.   Chrysant GS, Bakir S, Oparil S. Dietary salt reduction in hypertension—what is the evidence and why is it still controversial? Prog Cardiovasc Dis 1999.
• 54.   Rahn KH, Barenbrock M, Hausberg M. The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens 1999.
• 55.   N. I. Jowett, 1 and L. B. Cabot, 2 British Dental Journal Volume 189 No. 6 September 23 2000.
• 56.   Schwartz-Arad D, Bar-Tal Y, Eli I. Effect of stress on information processing in the dental implant surgery setting. Clin. Oral Impl. Res. 18, 2007; 9–12.
• 57.   Bra˚nemark P-I, Breine U, Adell R, Hansson B, Lindstrom€ J, Ohlsson A. Intra-osseous anchorage of dental prostheses: I. Experimental studies. Scand J PlastReconstrSurg Hand Surg 1969; 3:81–100.
• 58.   Albrektsson T, Bra˚nemark P-I, Hansson H-A, Lindstrom€ J. Osseointegrated titanium implants: requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop 1981; 52:155–170.
• 59.   Liu Y, Enggist L, Kuffer AF, Buser D, Hunziker EB. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 2007; 28:2677– 2686.
• 60.   Cuando A, Gomez-Moreno G, Arana C, et al. Melatonin stimulates osteointegration of dental implants. J Pineal Res 2008; 45:174–179.
• 61.   James W. Little, DMD, MSA Minneapolis, Minn University of Minnesota, (Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2000;90:591-9.
• 62.   Peacock M E, Carson R E. Frequency of selfreported medical conditions in periodontal
• 63.   Vaishnavi Devi. B, Priyalochana Gajendran, Delphine Priscilla Antony.S, European journal of research and clinical medicine. ISSN 2515-8260 volume 08- ISSUE 03, 2021.
• 64.   Debby Hwang, DMD, * and Hom-Lay Wang, DDS, MSD. Implant Dentistry / Volume 16, Number 1 2007.
• 65.   Moy PK, Medina D, Shetty V, Aghaloo TL (2005) Dental implant failure rates and associated risk factors. The Int J Oral Maxillofacial Impl 20(4): 569-577.
• 66.   Silverstein LH, Koch JP Lefkove MD, et al. (1995) Nifedipine-induced gingival enlargement around dental implants: A clinical report. J Oral Implantol
• 67.   Wu X, Abedalla K, Elmar H, Daniel NG, Nicolaus B, et al. (2016) Antihypertensive medications and survival rate of osseointegrated dental implants: A cohort study. Clin Implant Dent Relat Res 18[6]: 1171-1182.
• 68.   Scully C, Hobkirk J, Dios PD (2007) Dental endosseous implants in the medically
• 69.   DaisukeUeno, Junichi Sato, JunNejima, Keisuke Maruyama, Mariko Kobayashi, Toshikazu Iketani, ReiSekiguchi, Hiroshi Kawahara Int J Oral Maxillofacial Implants Nov-Dec 2012;27(6):1520-6.
• 70.   Taguchi I, Fukuda K, Sekine H, Kakizawa T (2011) Intravenous sedation and hemodynamic changes during dental implant surgery. Int J Oral Maxillofacial Impl 26(6): 1303-1308.
• 71.   Al-Subaie AE, Laurenti M, Abdallah MN, Tamimi I, Yaghoubi F, Eimar H, et al. Propranolol enhances bone healing and implant osseointegration in rats’ tibiae. J Clin Periodontal. 2016; 43:1160–70
• 72.   Wu X, Al-Abdalla K, Eimar H, et al. Antihypertensive medications and the survival
• 73.   Parihar, Anuj Singh et al. “Assessment of failure rate of dental implants in medically compromised patients.” Journal of family medicine and primary care vol. 9,2 883-885. 28 Feb. 2020.
• 74.   Liddelow G, Klineberg I. Patient-related risk factors for implant therapy. A critique of pertinent literature [Internet]. Vol. 56, Australian Dental Journal. 2011.

Data Sharing Statement

Funding